Bioincept, LLC
Records under this name other than patents Bioincept, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,737,585 | Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection Formerly held In force · High confidence | In force | High confidence | |
| US 10,953,071 | Compositions and Methods for Treatment of Intracellular Damage and Bacterial Infection Formerly held In force · High confidence | In force | High confidence | |
| US 11,096,987 | Mutant Peptides And Methods Of Treating Subjects Using The Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,458,681 | Compositions and Method for Treating Acute Radiation Syndrome Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,090,355 | Compositions And Methods For The Treatment Of Neurodamage Formerly held In force · High confidence | In force | High confidence | |
| US 7,723,290 | Compositions and Methods for Modulating the Immune System Formerly held Term ended Ended no later than Jan 29, 2025 · Medium confidence | Term ended | Ended no later than Jan 29, 2025 | Medium confidence |
| US 10,806,771 | Compositions And Methods For Modulating The Immune System Formerly held Term ended Ended no later than Jul 19, 2023 · Medium confidence | Term ended | Ended no later than Jul 19, 2023 | Medium confidence |
| US 7,273,708 | New Assays for Preimplantation Factor and Preimplantation Factor Peptides Term ended Ended no later than Dec 31, 2022 · Medium confidence | Term ended | Ended no later than Dec 31, 2022 | Medium confidence |
| US 7,723,289 | Pif Tetrapeptides Formerly held Term ended Term ended Dec 31, 2022 · Medium confidence | Term ended | Term ended Dec 31, 2022 | Medium confidence |
| US 8,222,211 | Methods of Administering Pif Agonist Peptides and Uses Thereof Formerly held Term ended Term ended Dec 31, 2022 · Medium confidence | Term ended | Term ended Dec 31, 2022 | Medium confidence |